Balsalazide Disodium Capsule
Product Images NDC 70771-1841

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Balsalazide Disodium (NDC 70771-1841). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Zydus Lifesciences Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Sturucture (82c71f40 Aa79 4446 B4a1 410d2ef8b81c 01)

Chemical structure of balsalazide disodium, showing the molecular components including aromatic rings, azo linkage, carboxylate groups, amide bond, and sodium atoms, along with two molecules of water of hydration (2 H2O).*

FDA Label Image

Figure 1 (82c71f40 Aa79 4446 B4a1 410d2ef8b81c 02)

A bar graph comparing the percentage of patients improved based on stool blood, stool frequency, and sigmoidoscopy evaluations. It contrasts two dosages of balsalazide disodium: 2.25 g (0.8 g mesalamine equivalents) and 6.75 g (2.4 g mesalamine equivalents). Each category shows higher improvement percentages for the 6.75 g dosage with associated p-values indicating statistical significance.*

FDA Label Image

Container Label (82c71f40 Aa79 4446 B4a1 410d2ef8b81c 03)

Label for Balsalazide Disodium Capsules, USP 750 mg by Zydus Lifesciences Limited. The label includes the NDC 70771-1841-1 and indicates a package size of 280 capsules for oral use. Storage instructions and child-resistant packaging warnings are present, along with a barcode and manufacturer address in Ahmedabad, India.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.